Search Results - "Pruijt, Johannes F M"

New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System by van Herk-Sukel, Myrthe P.P, van de Poll-Franse, Lonneke V, Lemmens, Valery E.P.P, Vreugdenhil, Gerard, Pruijt, Johannes F.M, Coebergh, Jan Willem W, Herings, Ron M.C

“…Abstract Background Insight into co-morbidity and treatment effects is pivotal to improve quality of care for cancer patients. Objectives To determine whether…”
Get full text

Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial by Oerlemans, Simone, Arts, Lindy Paulina Johanna, Kieffer, Jacobien M, Prins, Judith, Hoogendoorn, Mels, van der Poel, Marjolein, Koster, Ad, Lensen, Chantal, Stevens, Wendy Bernadina Catharina, Issa, Djamila, Pruijt, Johannes F M, Oosterveld, Margriet, van der Griend, René, Nijziel, Marten, Tick, Lidwine, Posthuma, Eduardus F M, van de Poll-Franse, Lonneke V

“…There has been a cultural shift toward patient engagement in health, with a growing demand from patients to access their results. The Lymphoma Intervention…”
Get full text

Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease by Huijsmans, Cornelis J J, Poodt, Jeroen, Damen, Jan, van der Linden, Johannes C, Savelkoul, Paul H M, Pruijt, Johannes F M, Hilbink, Mirrian, Hermans, Mirjam H A

“…During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an oncogene activating mutation, the mutant allele may be further…”
Get full text

Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis by Hoedemakers, Rein M J, Pruijt, Johannes F M, Hol, Suzanne, Teunissen, Elisa, Martens, Henk, Stam, Peter, Melsert, Roel, Te Velthuis, Henk

“…New monoclonal antibody-based assays for serum-free light chains (FLC) have become available. In a clinical study with 541 patients, the new N Latex FLC assays…”
Get more information

Persistent symptoms of fatigue, neuropathy and role‐functioning impairment among indolent non‐Hodgkin lymphoma survivors: A longitudinal PROFILES registry study by Ekels, Afke, Poll‐Franse, Lonneke V., Posthuma, Eduardus F. M., Kieffer, Jacobien, Issa, Djamila E., Koster, Adrianus, Nijziel, Marten R., Pruijt, Johannes H. F. M., Stevens, Wendy B. C., Tick, Lidwine W., Oerlemans, Simone

“…Summary Little is known about the long‐term health‐related quality of life (HRQoL) and persistence of symptoms among patients with indolent non‐Hodgkin…”
Get full text

Neutrophils Are Indispensable for Hematopoietic Stem Cell Mobilization Induced by Interleukin-8 in Mice by Johannes F. M. Pruijt, Verzaal, Perry, van Os, Ronald, Evert-Jan F. M. de Kruijf, Marianke L. J. van Schie, Mantovani, Alberto, Vecchi, Annunciata, Ivan J. D. Lindley, Willemze, Roel, Starckx, Sofie, Opdenakker, Ghislain, Fibbe, Willem E.

“…The CXC chemokine interleukin-8 (IL-8/CXCL8) induces rapid mobilization of hematopoietic progenitor cells (HPCs). Previously we showed that mobilization could…”
Get full text

Prevention of Interleukin-8-Induced Mobilization of Hematopoietic Progenitor Cells in Rhesus Monkeys by Inhibitory Antibodies against the Metalloproteinase Gelatinase B (MMP-9) by Johannes F. M. Pruijt, Fibbe, Willem E., veer, Laurens Later, Pieters, Reagan A., Ivan J. D. Lindley, Paemen, Liesbet, Masure, Stefan, Willemze, Roel, Opdenakker, Ghislain

“…Previously, we demonstrated that IL-8 induces rapid mobilization of hematopoietic progenitor cells (HPC) from the bone marrow of rhesus monkeys. Because…”
Get full text

Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry by Ezendam, Nicole P.M, Pijlman, Brenda, Bhugwandass, Celine, Pruijt, Johannes F.M, Mols, Floortje, Vos, M. Caroline, Pijnenborg, Johanna M.A, van de Poll-Franse, Lonneke V

“…Abstract Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neuropathy, and its impact on health-related quality…”
Get full text

Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort study by de Roij van Zuijdewijn, Camiel L.M., Westerweel, Peter E., Schipperus, Martin R., Pruijt, Johannes F.M., van de Loosdrecht, Arjan A., Beeker, Aart

“…•Anemia is common in patients with a myelodysplastic syndrome.•Transfusion-dependent MDS patients need 1–3 erythrocyte concentrations per month.•In…”
Get full text

Inflammatory bowel disease in Shwachman-Diamond syndrome; is there an association? by Nissen, Loes H.C., Stuurman, Kyra E., van der Feen, Cathelijne, Kemperman, Frits A., Pruijt, Johannes F.M., de Jonge, Hendrik J.M.

“…Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disease characterized by exocrine pancreatic insufficiency with malabsorption, malnutrition,…”
Get full text

Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression As First-Line Chemotherapy in Patients with HER2+ Metastatic Breast Cancer: HERTAX Trial by Hamberg, Paul, Bos, Monique M.E.M, Braun, Hans J.J, Stouthard, Jacqueline M.L, van Deijk, Gert A, Erdkamp, Frans L.G, van der Stelt-Frissen, Iris N, Bontenbal, Marijke, Creemers, Geert-Jan M, Portielje, Johanneke E.A, Pruijt, Johannes F.M, Loosveld, Olaf J.L, Smit, Willem M, Muller, Erik W, Schmitz, Paul I.M, Seynaeve, Caroline, Klijn, Jan G.M

“…Abstract Background Because chemotherapy for metastatic breast cancer (MBC) is associated with relevant toxicity, sequential monotherapy trastuzumab followed…”
Get full text

Enhancement of G-CSF–induced stem cell mobilization by antibodies against the β2 integrins LFA-1 and Mac-1 by Velders, Gerjo A., Pruijt, Johannes F.M., Verzaal, Perry, van Os, Ronald, van Kooyk, Yvette, Figdor, Carl G., de Kruijf, Evert-Jan F.M., Willemze, Roel, Fibbe, Willem E.

“…The β2 integrins leukocyte function antigen-1 (LFA-1, CD11a) and macrophage antigen-1 (Mac-1, CD11b) have been reported to play a role in the attachment of…”
Get full text

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era by Wensink, G. Emerens, Elferink, Marloes A. G., May, Anne M., Mol, Linda, Hamers, Patricia A. H., Bakker, Sandra D., Creemers, Geert-Jan, de Groot, Jan Willem B., de Klerk, Gerty J., Haberkorn, Brigitte C. M., Haringhuizen, Annebeth W., Hoekstra, Ronald, Hunting, J. Cornelis B., Kerver, Emile D., Mathijssen-van Stein, Danielle, Polée, Marco B., Pruijt, Johannes F. M., Quarles van Ufford-Mannesse, Patricia, Radema, Sandra, Rietbroek, Ronald C., Simkens, Lieke H. J., Tanis, Bea C., ten Bokkel Huinink, Daan, Tjin-A-Ton, Manuel L. R., Tromp-van Driel, Cathrien S., Troost, Monique M., van de Wouw, Agnes J., van den Berkmortel, Franchette W. P. J., van der Pas, Anke J. M., van der Velden, Ankie M. T., van Dijk, Marjan A., van Dodewaard-de Jong, Joyce M., van Druten, Edith B., van Voorthuizen, Theo, Jan Veldhuis, Gerrit, Verheul, Henk M. W., Vestjens, Hanneke J. H. M. J., Vincent, Jeroen, Kranenburg, Onno W., Punt, Cornelis J. A., Vink, Geraldine R., Roodhart, Jeanine M. L., Koopman, Miriam

“…Background Metastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm…”
Get full text

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma by van Bladel, Diede A. G., Stevens, Wendy B. C., Kroeze, Leonie I., de Groen, Ruben A. L., de Groot, Fleur A., van der Last-Kempkes, Jessica L. M., Berendsen, Madeleine R., Rijntjes, Jos, Luijks, Jeroen A. C. W., Bonzheim, Irina, van der Spek, Ellen, Plattel, Wouter J., Pruijt, Johannes F. M., de Jonge-Peeters, Susan D. P. W. M., Velders, Gerjo A., Lensen, Chantal, van Bladel, Esther R., Federmann, Birgit, Hoevenaars, Brigiet M., Pastorczak, Agata, van der Werff ten Bosch, Jutte, Vermaat, Joost S. P., Nooijen, Peet T. G. A., Hebeda, Konnie M., Fend, Falko, Diepstra, Arjan, van Krieken, J Han J. M., Groenen, Patricia J. T. A., van den Brand, Michiel, Scheijen, Blanca

“…•A considerable subset of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.•Assessment of T-cell clonality combined…”
Get full text

Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B‐cell Lymphoma by Berendsen, Madeleine R., Bladel, Diede A.G., Hesius, Eva, Berganza Irusquieta, Cristina, Rijntjes, Jos, Spriel, Annemiek B., Spek, Ellen, Pruijt, Johannes F.M., Kroeze, Leonie I., Hebeda, Konnie M., Croockewit, Sandra, Stevens, Wendy B.C., Krieken, J Han J.M., Groenen, Patricia J.T.A., Brand, Michiel, Scheijen, Blanca

“…Patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) occasionally develop diffuse large B‐cell lymphoma (DLBCL). This mostly results…”
Get full text

Single Nucleotide Polymorphism Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease by Huijsmans, Cornelis J. J, Poodt, Jeroen, Damen, Jan, van der Linden, Johannes C, Savelkoul, Paul H. M, Pruijt, Johannes F. M, Hilbink, Mirrian, Hermans, Mirjam H. A

“…During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an oncogene activating mutation, the mutant allele may be further…”
Get full text

Single Nucleotide Polymorphism by Huijsmans, Cornelis J. J, Poodt, Jeroen, Damen, Jan, van der Linden, Johannes C, Savelkoul, Paul H. M, Pruijt, Johannes F. M, Hilbink, Mirrian, Hermans, Mirjam H. A

“…During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an oncogene activating mutation, the mutant allele may be further…”
Get full text

Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1 by Velders, Gerjo A, Pruijt, Johannes F M, Verzaal, Perry, van Os, Ronald, van Kooyk, Yvette, Figdor, Carl G, de Kruijf, Evert-Jan F M, Willemze, Roel, Fibbe, Willem E

“…The beta 2 integrins leukocyte function antigen-1 (LFA-1, CD11a) and macrophage antigen-1 (Mac-1, CD11b) have been reported to play a role in the attachment of…”
Get full text

Leukemia Inhibitory Factor Induces In Vivo Expansion of Bone Marrow Progenitor Cells that Accelerate Hematopoietic Reconstitution but Do Not Enhance Radioprotection in Lethally Irradiated Mice by Pruijt, Johannes F. M., Lindley, Ivan J. D., Heemskerk, Diana P. M., Willemze, Roel, Fibbe, Willem E.

“…Leukemia inhibitory factor (LIF) is a pleiotropic cytokine with distinct hematopoietic activities. In vivo treatment of mice with recombinant murine LIF…”
Get full text

Comparison of the conical cuff and the standard rectangular cuffs by Maxwell, G F, Pruijt, J F, Arntzenius, A C

“…In this study the applicability of the conical cuff in the measurement of arterial blood pressure in the general population was investigated. A wide range of…”
Get more information